Single-base 2'OMe-modified LNA and MOE gapmers selectively silence <i>ACVR1</i> <sup><i>R206H</i></sup> in fibrodysplasia ossificans progressiva. [PDF]
Anwar S +5 more
europepmc +1 more source
Understanding the clinical morbidity and mortality of fibrodysplasia ossificans progressiva: a systematic literature review. [PDF]
Harrak H +4 more
europepmc +1 more source
An inducible knock-in mouse model of fibrodysplasia ossificans progressiva shows spontaneous formation of heterotopic ossification. [PDF]
Chakkalakal SA +6 more
europepmc +1 more source
Assessing the economic burden and health-related quality of life in chinese patients with fibrodysplasia ossificans progressiva: a questionnaire survey analysis. [PDF]
Xu X +7 more
europepmc +1 more source
Targeting to BMP9 to restrain flare-up of fibrodysplasia ossificans progressiva. [PDF]
Li Q, Yuan Q.
europepmc +1 more source
A Narrative Review of Phase II and III Clinical Trials for the Pharmacological Treatment of Fibrodysplasia Ossificans Progressiva (FOP): Efficacy, Safety, and Challenges in Treatment Strategies. [PDF]
Alharthi MS.
europepmc +1 more source
Clinical and radiological insights into fibrodysplasia ossificans progressiva: A report on two cases. [PDF]
Rapole S, Mehta B, Sodhai V.
europepmc +1 more source
Fibrodysplasia Ossificans Progressiva: A Man Turned to Stone. [PDF]
Kurtanović N +4 more
europepmc +1 more source
Fibrodysplasia Ossificans Progressiva: A Case Report. [PDF]
Qi L, Guo Y.
europepmc +1 more source

